×
For best experience we recommend to activate Javascript in your browser.
IL2RG antibody (AA 23-254)
The Mouse Monoclonal anti-IL2RG antibody (Clone 11n93) (ABIN2291724) specifically detects IL2RG in WB, FACS, ELISA and Neut.
The antibody is reactive with Human samples.
Catalog No. ABIN2291724
$1,084.29
Plus shipping costs $50.00
Delivery in 11 to 16 Business Days
Quick Overview for IL2RG antibody (AA 23-254) (ABIN2291724)
Target
See all IL2RG Antibodies
IL2RG
(Interleukin 2 Receptor, gamma (IL2RG))
Reactivity
All reactivities for IL2RG antibodies
Human
Host
All hosts for IL2RG antibodies
Mouse
Clonality
All clonalities for IL2RG antibodies
Monoclonal
Conjugate
All conjugates for IL2RG antibodies
This IL2RG antibody is un-conjugated
Application
All applications for IL2RG antibodies
Western Blotting (WB), Flow Cytometry (FACS), ELISA, Neutralization (Neut)
Clone
11n93
Product Details anti-IL2RG Antibody
(hide)
Binding Specificity
All epitopes for IL2RG antibodies
AA 23-254
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
IL2RG (Cytokine Receptor Common Subunit gamma, Interleukin-2 Receptor Subunit gamma, IL-2 Receptor Subunit gamma, IL-2R Subunit gamma, IL-2RG, p64, CD132)
Purification
Purified by Protein A affinity chromatography.
Endotoxin Level
Endotoxin: <0.10EU/ug (LAL)
Immunogen
Recombinant protein corresponding to aa23-254 from human IL-2 Receptor gamma expressed in S. frugiperda insect ovarian cell line Sf21 (P31785).
Isotype
IgG2b
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Lyophilized
Reconstitution
Reconstitute with 200 μL sterile PBS.
Buffer
Supplied as a lyophilized powder from PBS, 5 % trehalose.
Storage
-20 °C
Storage Comment
-20°C
Target Details for IL2RG
(hide)
Target
IL2RG
(Interleukin 2 Receptor, gamma (IL2RG))
Alternative Name
IL2RG
UniProt
P31785
Pathways
JAK-STAT Signaling , Growth Factor Binding
Recently viewed
(hide)
Chat with us , powered by LiveChat